TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05155293 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05548127 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05756465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04863898 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05934539 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT04912856 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT04793100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05690035 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT05690035 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT06125262 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06128148 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05486338 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05111080 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01200017 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04897620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05926791 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT06592443 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06615024 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05621655 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05338957 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05094596 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05094596 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05094596 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06613581 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06207318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06207318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04710121 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06696183 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05074875 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05091086 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05735158 — Predictive Biomarker (PRD): TGM1 mRNA
Genes: TGM1; KTG
Study NCT05141786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00000755 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05562830 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03978117 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study NCT06452706 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06452706 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06450691 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05849688 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06677580 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06043466 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06678074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06678074 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06408402 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT05525338 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05496673 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06112834 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04608630 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04315324 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT04590781 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT04886414 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05866445 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06046326 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT05876351 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04205032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05323929 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT06080776 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06080776 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05633147 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06055309 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06479460 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04888949 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05683860 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT04857151 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05607563 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06422481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04791488 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04792489 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06098651 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT06013111 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06188195 — Predictive Biomarker (PRD): SGK1 mRNA
Genes: SGK1; SGK
Study NCT05423977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06094920 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06094920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05015972 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06616805 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT06616805 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05397015 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05397015 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT05397015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06465875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05308836 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04735588 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05898763 — Predictive Biomarker (PRD): LRPAP1 mRNA
Genes: LRPAP1; A2MRAP
Study NCT05898763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05425745 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04832971 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT04832971 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06078540 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06147414 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05681416 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05681416 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study NCT04687241 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04687241 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05725902 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04954859 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05283330 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT05180045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04846647 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06605625 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06677788 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06677788 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT04761393 — Predictive Biomarker (PRD): MMP12 mRNA
Genes: MMP12; HME
Study NCT06210945 — Predictive Biomarker (PRD): CCL24 mRNA
Genes: CCL24; MPIF2; SCYA24
Study NCT04969354 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT05021484 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05854706 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05854706 — Safety Biomarker (SAF): BDNF
Study NCT05423951 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04913519 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT00059449 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05992987 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05992987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04854213 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06132776 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT06013345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06519760 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT05265065 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06555263 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06615128 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT06685276 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06685276 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05535660 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05535660 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05374915 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05335811 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05387070 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06117787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05268419 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05017649 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT05610449 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05911087 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04201028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04554147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05412394 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05505305 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06338631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05252247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04526899 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06696846 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05422313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05422313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06513949 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT04855396 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04855396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05472896 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT06401408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04540692 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05416099 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05397223 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06157463 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06157463 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06157463 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06351696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06351696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05290337 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT04944069 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06617494 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT06678555 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06678555 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT06370936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06552507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02483936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05847764 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06347926 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06326528 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04285827 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05922631 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05922631 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06319248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05367765 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05367765 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05867524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06307041 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05643716 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study NCT05643716 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT05279638 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study NCT06550063 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05105152 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT06576596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06435299 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT06032234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06032234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04938817 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05618899 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04963608 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06613269 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT06678685 — Predictive Biomarker (PRD): NCOR1 mRNA
Genes: NCOR1; KIAA1047
Study NCT05291949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05665153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05746117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06347718 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05631535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05274048 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06234319 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06360029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06267872 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04517851 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT04517851 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06331117 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05393128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05736367 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05736367 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05736367 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05498389 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT05498389 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04845841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05045924 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05621954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06015113 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05227131 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01469507 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04849364 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06614751 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06614751 — Predictive Biomarker (PRD): PARG mRNA
Genes: PARG
Study NCT06615934 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06615934 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06616818 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05414617 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05669833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04958967 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04554069 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05775380 — Predictive Biomarker (PRD): SPHK1 mRNA
Genes: SPHK1; SK1; SPHK; SPK
Study NCT05775380 — Predictive Biomarker (PRD): S1PR1 mRNA
Genes: S1PR1; CHEDG1; EDG1
Study NCT04926064 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05647707 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04565496 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06365684 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00002438 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05159908 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT06068777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04648046 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04783415 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05546099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00146029 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00022841 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04934852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04084574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05960019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06217731 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06217731 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT06217731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06217731 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT06217731 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06217731 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): IL21 mRNA
Genes: IL21
Study NCT06217731 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06217731 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06217731 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06217731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06055673 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00002194 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05847608 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05423080 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04910828 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06446388 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05487755 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05361486 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05580861 — Predictive Biomarker (PRD): SLC7A11 mRNA
Genes: SLC7A11
Study NCT05282459 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06031220 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06490887 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05131763 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT06556004 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06647485 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06593054 — Predictive Biomarker (PRD): CTBS mRNA
Genes: CTBS; CTB
Study NCT06593054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06649851 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06658522 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT06588205 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05550376 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05550376 — Predictive Biomarker (PRD): ACVRL1 mRNA
Genes: ACVRL1; ACVRLK1; ALK1
Study NCT05236842 — Predictive Biomarker (PRD): SULT1A3 mRNA
Genes: SULT1A3; STM
Study NCT04998812 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05451940 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05721950 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK